The IPO Buzz: Boundless Bio Prices IPO at $16.00 Mid-Point – Stock Drops in NASDAQ Debut
Boundless Bio (BOLD) priced its IPO at $16.00 – the mid-point of its range – on just 6.25 million shares – the number of shares in the prospectus – to raise $100.0 million on Wednesday night, March 27, 2024. The Phase 1/Phase 2 cancer biotech’s stock sank in its first day of NASDAQ trading on Thursday, March 28, 2024. Boundless Bio finished right where it started - down 10.94 percent..
Read more March 28, 2024IPO Calendar
Company | Symbol proposed | Shares (Millions) | Est. $ Volume | Expected to Trade | SCOOP Rating | Rating Change |
---|---|---|---|---|---|---|
U-BX Technology Ltd. | UBXG | 2.0 | $ 10.0 mil | 3/28/2024 Priced | S/O | S/O |
Massimo Group | MAMO | 1.3 | $ 5.9 mil | 4/2/2024 Tuesday | S/O | S/O |
Zhibao Technology | ZBAO | 1.2 | $ 6.0 mil | 4/2/2024 Tuesday | S/O | S/O |
Last 100 IPOs - March 28, 2024
Number of IPOs priced : | 100 |
Number Up: | 32 |
Number Down: | 67 |
Number Unchanged: | 1 |
Percentage Change From Issue Price: | 7.08% |
Percentage Change for The Nasdaq Composite | 20.66% |
2024 IPO Scorecard - March 28, 2024
Number of IPOs priced (Excluding 6 units) : | 38 |
Number Up: | 15 |
Number Down: | 22 |
Number Unchanged: | 1 |
Total Return From Issue Price: | 12.74% |
The Nasdaq Composite Index YTD % Change | 9.25% |